Skip to main content
. 2023 Feb 2;12(2):140–151. doi: 10.21037/gs-22-480

Table 3. Analysis of the quantitative variables as possible predictors of involvement of the remaining axillary nodes and SN false-negatives and false-positives, Mann-Whitney U test.

Features Remaining axillary nodes status SN false-negatives SN false-positives
None metastatic (n=12), mean (SD) >1 metastatic LNs (n=13), mean (SD) P No FN (n=18), mean (SD) FN (n=7), mean (SD) P No FP (n=20), mean (SD) FP (n=5), mean (SD) P
Age (years) 51.66 (7.88) 59.23 (13.93) 0.13 58.85 (17.78) 54.3 (8.9) 0.74 56.45 (12.73) 52.20 (7.39) 0.53
Body mass index (kg/m2) 27.61 (6.46) 24.52 (4.48) 0.20 26.41 (5.71) 24.95 (5.70) 0.53 26.29 (5.62) 24.85 (6.16) 0.45
Suspicious node US size (mm) 14.08 (4.94) 16.07 (7.02) 0.61 14.94 (5.10) 15.57 (8.58) 0.83 14.75 (6.12) 16.60 (6.30) 0.45
ER (%) 94.08 (6.11) 90.53 (19.08) 0.76 95 (5.47) 85.14 (25.3) 0.70 91.45 (15.72) 95.40 (4.92) 0.81
PR (%) 74.58 (32.54) 54.23 (41.45) 0.34 63.27 (36.26) 65.85 (45.58) 0.65 60.15 (39.93) 79.40 (27.75) 0.30
Ki67 index (%) 16.66 (12.30) 24.61 (13.14) 0.06 17.22 (10.60) 30 (15.27) 0.02 21.25 (12.12) 19.00 (18.16) 0.33
Invasive tumor size (mm) 27.60 (29.06) 41.27 (68.30) 0.61 27.52 (26.19) 53.20 (92.60) 0.70 38.56 (58.36) 19.32 (7.87) 0.92
Tumor size including DCIS (mm) 30.50 (35.24) 48.50 (67.87) 0.25 29.65 (30.36) 65.97 (89.76) 0.13 43.99 (61.18) 26.02 (15.52) 0.89
Biopsy proven LN size on the pathology report (mm) 21.50 (5.97) 22.15 (7.25) 0.89 21.27 (6.25) 23.28 (7.54) 0.458 22.10 (7.25) 20.80 (2.28) 0.86
Number of SNs excised 1 (1.04) 1.69 (1.49) 0.27 1.55 (1.33) 0.85 (1.21) 0.27 1.25 (1.40) 1.8 (0.83) 0.30
Final number of LNs excised 14.41 (6.21) 12.76 (4.85) 0.61 13.66 (5.48) 13.28 (5.93) 0.79 13.85 (5.77) 12.40 (4.50) 0.76

SN, sentinel node; SD, standard deviation; LN, lymph node; FN, false negative; FP, false positive; US, ultrasound; ER, estrogen receptor; PR, progesterone receptor; DCIS, ductal carcinoma in situ.